Skip to main content
Caplight Logo









Gazella Biotech

Gazella Biotech

Private
SpainHealthcare & Life Scienceshttps://gazellabiotech.com/

Last Round

Grant

Dec 4, 2025

Total Funding Raised

$1.19M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Gazella Biotech is a biotechnology company that develops advanced therapies for the treatment of metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

metabolic diseasesobesity treatmentweight loss drugsadvanced therapiestargeted therapytherapeutic platformbiotech R&Ddrug developmentpreclinical biotechmetabolic drugsCNS therapypharmaceutical licensinguniversity spin-off

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gazella Biotech Comparables

Compare Gazella Biotech with similar companies based on industry and business-model similarity.

Gazella Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Courage Therapeutics
81%
Biolexis Therapeutics, Inc.
77%
Saniona AB
70%

Gazella Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 4, 2025
SeedApr 1, 2024

Gazella Biotech Investors

Notable investors and investment history

Gazella Biotech investors
InvestorRounds
Agencia Estatal de InvestigaciónGrant
NowtureSeed
Unirisco GaliciaSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 79% MoM to 1.7K.

  • Dec 4, 2025

    $1.13M grant received from Agencia Estatal de Investigación.

Gazella Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gazella Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gazella Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersSpain
Employee Range2
Year FoundedN/A
Last FundingDec 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?